Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowApril 18, 2024 — 9:15 AM - 9:45 AM ET
Nasdaq MarketSite, 4 Times Square, New York
Skye Bioscience (Nasdaq: SKYE), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, with an emphasis on obesity and ocular indications, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Punit Dhillon, CEO, rings the Opening Bell.